Digital Marketing Trends in Psoriasis

Digital Marketing Trends in Psoriasis Report Overview 

AbbVie’s Skyrizi.com achieved the highest total traffic across branded PsO patient sites in the US with almost 7.2 million visitors between January 2022-December 2022. This was followed by Novartis’s Cosentyx.com (3.3 million visits) and AbbVie’s Humira.com (2.3 million visits). Amgen spent the most on digital display advertising (DDA) for Otezla.com, followed by Enbrel.com. Cosentyx.com was supported by the most paid search engine optimization, followed by Otezla.com and Stelarainfo.com. The digital marketing trends in Psoriasis research report will help to understand the digital marketing competitive landscape in Psoriasis.

Major US Patient Branded Websites for Psoriasis

The major US patient-branded websites for Psoriasis are Skyrizi.com, Cosentyx.com, Humira.com, Enbrel.com, Tremfya.com, Otezla.com, and Stelarainfo.com. Between January 2022 and December 2022, AbbVie’s Skyrizi.com achieved the highest total traffic across PsO patient sites in the US.

Digital Marketing Trends in Psoriasis by US Patient-Branded Websites, 2022 (%)

 For more insights into the total traffic engagement of the US patient branded websites, download a free report sample

Major US HCP Branded Websites for Psoriasis

The major US HCP-branded websites for Psoriasis are Enbrelpro.com, Otezlapro.com, Skyrizihcp.com, Sotyktuhcp.com, Humirapro.com, Cosentyxhcp.com, and Tremfyahcp.com. Amgen’s Enbrelpro.com achieved the highest total traffic between January 2022 and December 2022.

Digital Marketing Trends in Psoriasis, by US HCP Branded Websites, 2022 (%)

 For more insights on total traffic engagement of the US HCP branded websites, download a free report sample

US Branded HCP Websites Paid SEO and DDA Spend for Psoriasis

Otezlapro.com was supported by the most paid SEO, followed by Enbrelpro.com and BMS’s Sotyktuhcp.com. Amgen spent the most on DDA for Enbrelpro.com, followed by Otezlapro.com. Minimal DDA was detected for Tremfyahcp.com, Skyrizihcp.com, and Cosentyxhcp.com.

US Branded HCP Websites, by Paid SEO, 2022 (%)

 For more insights into the paid SEO spending of branded US HCP patient sites, download a free report sample

US Branded Patient Websites Paid SEO and DDA Spend for Psoriasis

Cosentyx.com was supported by the most paid SEO, closely followed by Otezla.com and Stelarainfo.com. Amgen spent the most on DDA for Otezla.com, followed by Enbrel.com, Janssen’s Stelarainfo.com, and Novartis’s Cosentyx.com. The top publisher of ads across the 12-month period was YouTube, followed by Google Display Network and Google DV 360.

US Branded Patient Websites by Paid SEO, 2022 (%)

 For more insights into the paid SEO spending of branded US patient sites, download a free report sample

Top US Social Media Activity in PsO

The post with the highest interaction was from Arcutis Biotherapeutics’ Twitter account which promoted the FDA approval of Zoryve for the treatment of adults and adolescents with plaque PsO. The next highest PsO post by interaction was on the Lilly Dermatology Twitter page on World Psoriasis Day, reinforcing its commitment to those who live with PsO and highlighting symptoms such as skin discoloration, plaques, and silvery-white scales.

Top EUCAN Social Media Activity in PsO

The post with the highest interaction was from LEO Pharma’s Italia Facebook account. It highlighted the importance of a diet rich in unsaturated fatty acids, phenolic compounds, vitamins, proteins, and minerals for PsO patients, and linked to its unbranded Psopeople.it site. The next highest PsO post by interaction was on Novartis’s unbranded Italian La Pelle Conta Instagram account for World Psoriasis Day and raised awareness about the psychological impact of PsO.

Psoriasis Digital Marketing Report Overview

Scope

This report assesses key digital marketing metrics of pharma assets in PsO, including branded websites for patients and HCPs, Unbranded websites, and social media accounts.

Reasons to Buy

• Understand the digital marketing competitive landscape in PsO, with a view of leading patient and HCP branded assets across different regions.
• See what tactics pharma companies are using to drive traffic to their PsO branded assets for patient and HCPs, such as DDA and paid SEO.
• Understand what sources of website traffic are generating the most visits to these assets, such as paid SEO, social media, or organic searches.
• Compare top branded and unbranded assets for patients by how they address and support different patient needs.
• See what pharma social media accounts in PsO are the most active and achieving the most engagement.